July 29, 2014 1:21 AM ET

Pharmaceuticals

Company Overview of KAI Pharmaceuticals, Inc.

Executive Profile

Randolph M. Johnson Ph.D.

Former Vice President of Preclinical Research and Director of Central Nervous System Programs, DURECT Corporation
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

63--

Background

Dr. Randolph M. Johnson, Ph.D., serves as Chief of Technology Development and Vice President of Research at KAI Pharmaceuticals, Inc. Dr. Johnson joined KAI Pharmaceuticals, Inc. in August 2008. He served as Senior Vice President of Research and Preclinical Development of Progen Pharmaceuticals, Inc. (known as CellGate Inc). He has over 20 years of combined experience in pharmaceutical and biopharmaceutical research and development. He served as Vice President of Preclinical ...

Corporate Headquarters

270 Littlefield Avenue
South San Francisco, California 94080-6924

United States

Phone: 650-244-1100
Fax: 650-244-1199

Board Members Memberships

There is no Board Members Memberships data available.

Education

MA
California State University
BS
California State University
MA
California State University, Long Beach
BS
California State University, Long Beach
PhD
University of South Carolina School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Jack A. Khattar Founder, Chief Executive Officer, President, Secretary and Director
Supernus Pharmaceuticals, Inc.
$462.9K
Nasrat Hakim Chief Executive Officer, President and Director
Elite Pharmaceuticals, Inc.
$378.1K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAI Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.